Hulsbergen-van de Kaa CA - Search Results

1

Regulation of MYCN expression in human neuroblastoma cells.

Jacobs JF, van Bokhoven H, van Leeuwen FN, Hulsbergen-van de Kaa CA, de Vries IJ, Adema GJ, Hoogerbrugge PM, de Brouwer AP. Jacobs JF, et al. BMC Cancer. 2009 Jul 18;9:239. doi: 10.1186/1471-2407-9-239. BMC Cancer. 2009. PMID: 19615087 Free PMC article.

2

Cancer-germline gene expression in pediatric solid tumors using quantitative real-time PCR.

Jacobs JF, Brasseur F, Hulsbergen-van de Kaa CA, van de Rakt MW, Figdor CG, Adema GJ, Hoogerbrugge PM, Coulie PG, de Vries IJ. Jacobs JF, et al. Int J Cancer. 2007 Jan 1;120(1):67-74. doi: 10.1002/ijc.22118. Int J Cancer. 2007. PMID: 17019710 Free article.

3

Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patients.

Desar IM, Jacobs JH, Hulsbergen-vandeKaa CA, Oyen WJ, Mulders PF, van der Graaf WT, Adema GJ, van Herpen CM, de Vries IJ. Desar IM, et al. Int J Cancer. 2011 Jul 15;129(2):507-12. doi: 10.1002/ijc.25674. Epub 2010 Nov 12. Int J Cancer. 2011. PMID: 20839259 Free article.

4

Real-time analysis of tyrosine hydroxylase gene expression: a sensitive and semiquantitative marker for minimal residual disease detection of neuroblastoma.

Lambooy LH, Gidding CE, van den Heuvel LP, Hulsbergen-van de Kaa CA, Ligtenberg M, Bökkerink JP, De Abreu RA. Lambooy LH, et al. Clin Cancer Res. 2003 Feb;9(2):812-9. Clin Cancer Res. 2003. PMID: 12576454

5

Development of a high-field MR-guided HIFU setup for thermal and mechanical ablation methods in small animals.

Hoogenboom M, van Amerongen MJ, Eikelenboom DC, Wassink M, den Brok MH, Hulsbergen-van de Kaa C, Dumont E, Adema GJ, Heerschap A, Fütterer JJ. Hoogenboom M, et al. J Ther Ultrasound. 2015 Aug 13;3:14. doi: 10.1186/s40349-015-0035-6. eCollection 2015. J Ther Ultrasound. 2015. PMID: 26269744 Free PMC article.

6

Prevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma: results from The Netherlands cohort study.

van Houwelingen KP, van Dijk BA, Hulsbergen-van de Kaa CA, Schouten LJ, Gorissen HJ, Schalken JA, van den Brandt PA, Oosterwijk E. van Houwelingen KP, et al. BMC Cancer. 2005 Jun 2;5:57. doi: 10.1186/1471-2407-5-57. BMC Cancer. 2005. PMID: 15932632 Free PMC article.

7

Metastatic rhabdomyosarcoma cured after chemotherapy and allogeneic SCT.

Donker AE, Hoogerbrugge PM, Mavinkurve-Groothuis AM, van de Kar NC, Boetes C, Hulsbergen-van de Kaa CA, Groot-Loonen JJ. Donker AE, et al. Bone Marrow Transplant. 2009 Jan;43(2):179-80. doi: 10.1038/bmt.2008.301. Epub 2008 Sep 1. Bone Marrow Transplant. 2009. PMID: 18762761 No abstract available.

8

Intermediate cells in normal and malignant prostate epithelium express c-MET: implications for prostate cancer invasion.

van Leenders G, van Balken B, Aalders T, Hulsbergen-van de Kaa C, Ruiter D, Schalken J. van Leenders G, et al. Prostate. 2002 May 1;51(2):98-107. doi: 10.1002/pros.10073. Prostate. 2002. PMID: 11948964

9

Familial aggregation of urothelial cell carcinoma.

Aben KK, Witjes JA, Schoenberg MP, Hulsbergen-van de Kaa C, Verbeek AL, Kiemeney LA. Aben KK, et al. Int J Cancer. 2002 Mar 10;98(2):274-8. doi: 10.1002/ijc.10191. Int J Cancer. 2002. PMID: 11857419 Free article.

10

Isolation of osteosarcoma-associated amplified DNA sequences using representational difference analysis.

Simons A, Janssen IM, Suijkerbuijk RF, Veth RP, Pruszczynski M, Hulsbergen-van de Kaa CA, du Manoir S, Geurts van Kessel A. Simons A, et al. Genes Chromosomes Cancer. 1997 Oct;20(2):196-200. doi: 10.1002/(sici)1098-2264(199710)20:2<196::aid-gcc10>3.0.co;2-p. Genes Chromosomes Cancer. 1997. PMID: 9331570 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

154 results

Search Page